The Role of NF-κB in Chronic Rhinosinusitis With Nasal Polyps

다국어 초록 (Multilingual Abstract)

Purpose: Whereas the majority of nasal polyps observed in Western populations are eosinophilic, non-eosinophilic nasal polyps are significantly more frequent in Asian countries. Given the importance of nuclear factor-kappa B (NF-κB) in inflammation, this study focused on the role of NF-κB in the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNPs) in Asian patients.
Methods: A total of 46 patients were enrolled in this study (22 diagnosed with CRSwNPs, 10 with chronic rhinosinusitis without nasal polyps [CRSsNP], and 14 control subjects). Nasal polyps and uncinate tissues (UTs) were collected and the tissues prepared for hematoxylineosin staining and immunohistochemistric (IHC) analysis. Total RNA was isolated for real-time polymerase chain reaction for p65, interleukin (IL)-6, IL-8, intracellular adhesion molecule (ICAM)-1, IL-1β, tumor necrosis factor (TNF)-α, and eotaxin.
Results: In the CRSwNPs group, 50% of nasal polyps were non-eosinophilic. IHC revealed a significantly higher fraction of NF-κB p65-positive cells in nasal polyps of the CRSwNPs group than in the UTs of control and CRSsNP groups. No difference in NF-κB p65-positive cell fraction was observed between eosinophilic and non-eosinophilic nasal polyps. The mRNA expression of p65, IL-6, IL-8, and eotaxin was significantly higher in nasal polyps of the CRSwNPs than in the UTs of control and CRSsNP group. However, no difference in expression was observed between eosinophilic and non-eosinophilic nasal polyps, with the exception of IL-1β expression.
Conclusions: Elevated expression of NF-κB- and NF-κB-associated inflammatory cytokines suggests NF-κB as the key factor for CRSwNPs pathogenesis in Asian patients.
Understanding NF-κB-associated mechanisms will provide a deeper insight into CRSwNPs pathogenesis and ultimately improve therapeutic strategies for CRSwNPs.

참고문헌 (Reference)

1 Lawrence T, "The nuclear factor NF-κB pathway in inflammation" 1 : a001651-, 2009

2 Valera FC, "Suppression of inflammatory cytokine secretion by an NF-κB inhibitor DHMEQ in nasal polyps fibroblasts" 30 : 13-22, 2012

3 Meltzer EO, "Rhinosinusitis : establishing definitions for clinical research and patient care" 114 : 155-212, 2004

4 Barnes PJ, "Nuclear factor-κB : a pivotal transcription factor in chronic inflammatory diseases" 336 : 1066-1071, 1997

5 Takeno S, "Nuclear factor-kappa B activation in the nasal polyp epithelium : relationship to local cytokine gene expression" 112 : 53-58, 2002

6 Kirtsreesakul V, "Nasal polyps : the relationship to allergy, sinonasal infection and histopathological type" 87 : 277-282, 2004

7 Vento SI, "Nasal polyposis : clinical course during 20years" 85 : 209-214, 2000

8 Pawankar R, "Nasal polyposis : an update : editorial review" 3 : 1-6, 2003

9 Frączek M, "Microarray analysis of NF-κB-dependent genes in chronic rhinosinusitis with nasal polyps" 22 : 209-217, 2013

10 Necela BM, "Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells" 1 : 239-246, 2004

11 Lennard CM, "Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis : response to systemic corticosteroids" 14 : 367-373, 2000

12 Daines SM, "Inflammatory cytokines in allergy and rhinosinusitis" 18 : 187-190, 2010

13 Wilson SJ, "Immunohistochemical analysis of the activation of NF-κB and expression of associated cytokines and adhesion molecules in human models of allergic inflammation" 189 : 265-272, 1999

14 Kim JW, "Histological and immunological features of noneosinophilic nasal polyps" 137 : 925-930, 2007

15 Papon JF, "HLA-DR and ICAM-1expression and modulation in epithelial cells from nasal polyps" 112 : 2067-2075, 2002

16 Gevaert P, "Global Resources in Allergy™. Chronic rhinosinusitis and nasal polyposis (module 10)" World Allergy Organization 2011

17 Baeuerle PA, "Function and activation of NF-κB in the immune system" 12 : 141-179, 1994

18 Silvestri M, "Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling" 128 : 51-58, 2002

19 Fokkens WJ, "European position paper on rhinosinusitis and nasal polyps 2012" 23 : 1-298, 2012

20 Henriksson G, "Effects of topical budesonide treatment on glucocorticoid receptor mRNA down-regulation and cytokine patterns in nasal polyps" 15 : 1-8, 2001

21 Hao J, "Diffuse mucosal inflammation in nasal polyps and adjacent middle turbinate" 134 : 267-275, 2006

22 Zhang N, "Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease" 122 : 961-968, 2008

23 Lund VJ, "Diagnosis and treatment of nasal polyps" 311 : 1411-1414, 1995

24 Adcock IM, "Cross-talk between pro-inflammatory transcription factors and glucocorticoids" 79 : 376-384, 2001

25 Larsen K, "Clinical course of patients with primary nasal polyps" 114 : 556-559, 1994

26 Jareoncharsri P, "Clinical and histopathological classification of nasal polyps in Thais" 54 : 689-697, 2002

27 Soler ZM, "Chronic rhinosinusitis, race, and ethnicity" 26 : 110-116, 2012

28 Phan NT, "Cellular and molecular mechanisms of chronic rhinosinusitis and potential therapeutic strategies: review on cytokines, nuclear factor kappa B and transforming growth factor beta" 129 (129): S2-S7, 2015

29 Tikaram A, "Asian nasal polyps : a separate entity" 68 : 445-447, 2013

30 Xu R, "A correlative study of NF-κB activity and cytokines expression in human chronic nasal sinusitis" 121 : 644-649, 2007